Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Dupuytren Contracture 3Contracture 1Connective Tissue Diseases 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × xiapex × Clear all
NCT03192020 2026-04-29

DETECT

Tampere University

Phase 4 Active not recruiting
302 enrolled

Connective Tissue Diseases, Contracture, Dupuytren Contracture

NCT02647619 2022-04-26

Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

University Hospital, Akershus

Phase 4 Completed
80 enrolled

Dupuytren Contracture

NCT02476461 2015-06-19

PNFvsxiapex

Oslo University Hospital

Phase 4 Unknown
50 enrolled

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡